Department of Dermatology, Anhui Provincial Children's Hospital, Children's Hospital of Anhui Medical University, Hefei, Anhui, 230022, China.
Lasers Med Sci. 2024 Jun 27;39(1):164. doi: 10.1007/s10103-024-04113-z.
Telangiectasias are the most frequent type of sequelae of infantile hemangiomas after involution. Few studies have reported the treatment of telangiectasias with 595-nm pulsed dye lasers. Therefore, the objective of this study was to assess the efficacy and safety of a 595-nm pulsed dye laser for treating residual telangiectasias following hemangioma involution. This is a retrospective case series that analyzes the medical records and reviews the charts of 22 patients who had undergone 595-nm pulsed dye laser treatment for residual telangiectasias. Pre- and post-treatment digital images were independently assessed, and the changes were scored to ascertain the efficacy of the treatment (0 = no change, 4 = complete improvement). Of the 22 patients, 59.1% experienced complete resolution of telangiectasias following treatment. No serious complications or side effects were reported. The observations indicate that the 595-nm pulsed dye laser is effective and safe for treating residual telangiectasias following hemangioma involution.
毛细血管扩张症是婴儿血管瘤消退后的最常见后遗症类型。很少有研究报告过用 595nm 脉冲染料激光治疗毛细血管扩张症。因此，本研究的目的是评估 595nm 脉冲染料激光治疗血管瘤消退后残留毛细血管扩张症的疗效和安全性。这是一项回顾性病例系列研究，分析了 22 例接受 595nm 脉冲染料激光治疗残留毛细血管扩张症的患者的病历和图表。对治疗前后的数字图像进行了独立评估，并对变化进行评分以确定治疗效果（0=无变化，4=完全改善）。在 22 例患者中，59.1%的患者在治疗后完全消除了毛细血管扩张症。未报告严重并发症或副作用。观察结果表明，595nm 脉冲染料激光治疗血管瘤消退后残留毛细血管扩张症是有效且安全的。
